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Knee osteoarthritis and risk of incident cardiovascular disease.
Hazard ratio (95%CI) P-value
Total CVD (n¼1230)
Radiographic OA Model1 1.00 (0.87 to 1.15) 0.96
Model2 0.99 (0.86 to 1.15) 0.92
Clinical OA Model1 1.08 (0.88 to 1.33) 0.45
Model2 1.09 (0.88 to 1.34) 0.43
Self-reported OA Model1 1.08 (0.93 to 1.24) 0.32
Model2 1.09 (0.94 to 1.26) 0.26
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people with hip chondropathy demonstrate impaired balance ability
during a dynamic single-leg squat with eyes open (SquatEO) and single-
leg standing task with eyes closed (StandEC), relative to controls. A
secondary aim was to explore whether hip range of motion (ROM) and
hip muscle strength were correlated to balance measures in the hip
chondropathy group.
Methods: 63 adults (36 female, mean [SD] age: 37.6 [11.6] years) with
hip chondropathy (diagnosed arthroscopically using the Outerbridge
classiﬁcation for chondral damage in the previous 12-24 months) and
60 healthy controls (41 female, mean [SD] age: 35.7 [9.7] years) per-
formed two single-leg balance tasks: SquatEO and StandEC while
standing on a Nintendo WiiTM balance board. Tests were performed
barefoot, on the surgical leg of hip chondropathy participants and
dominant leg of controls. Centre of pressure (CoP) total path velocity,
range and standard deviation (SD) of CoPmovement in themediolateral
(ML range & MLSD) and anterior-posterior direction (AP range & APSD)
were extracted. Hip ROM and muscle strength were measured with an
inclinometer and hand-held dynamometer. Data were analysed using
a one-way ANOVA and stepwise multiple regression. The alpha level
was set to 0.05.
Results: During the SquatEO, greater CoPML range (P¼0.001) and APSD
(P¼0.030) was observed in those with hip chondropathy compared to
healthy controls. No signiﬁcant between-group differences were
observed for any of the balance measures during the StandEC (P>0.05).
Multiple regression analyses identiﬁed hip external rotation ROM as
being signiﬁcantly associated with ML range during the SquatEO
(P¼0.005). When performing the SquatEO, hip external rotation ROM
accounted for 11% of the variance in CoP ML range. No hip measure-
ments were correlated to APSD during the SquatEO.
Conclusions: Dynamic single-leg balance squat performance is reduced
in young adults with hip chondropathy compared to healthy adults, but
single-leg standing balance is not. CoP ML range and APSD were
signiﬁcantly greater in those with hip chondropathy relative to controls,
which can be interpreted as reduced control of dynamic movements.
This study suggests early signs of hip joint degeneration can impair
postural control mechanisms, particularly during dynamic tasks incor-
porating an internal perturbation. Those with greater hip joint external
rotation motion appear to have worse single-leg squat balance perfor-
mance. Further investigation into balance deﬁcits associated with hip
disease is necessary to establish early-identiﬁcation strategies and
a more tailored-approach to rehabilitation. Greater understanding of
mechanical, muscular and neurophysiological processes for balance
control in adults with hip chondropathy, early- and advanced hip OA is
essential.74
DISABILITY AND NOT OSTEOARTHRITIS PREDICTS CARDIOVASCULAR
DISEASE; A PROSPECTIVE POPULATION-BASED COHORT STUDY
T.A. Hoeven, M.J. Leening, P.J. Bindels, M. Castano-Betancourt,
J.B. van Meurs, O.H. Franco, M. Kavousi, A. Hofman, A.M. Ikram,
J.C. Witteman, S.M. Bierma-Zeinstra. Erasmus MC, Rotterdam, Netherlands
Purpose: Osteoarthritis (OA) is associated with many comorbid
conditions, and a recent interest in linking osteoarthritis to car-
diometabolic disorders has emerged. Several cross-sectional and
disease-speciﬁc mortality studies suggest an association between OA
and cardiovascular disease (CVD). This association might arise from
different potential mechanisms. Possibly, they are concurrent diseases
that share aetiological features and risk factors. Otherwise, athero-
sclerotic disease might play an initiating role by causing microcircula-
tory disturbances in the synovial membrane and subchondral bone that
contribute to the cartilage destruction and pathophysiological process
of OA. However, we found no indications for this latter pathway in
a large-scale longitudinal study. Finally, OA might lead to a sedentary
lifestyle, disability and therefore an increased risk of CVD. For the
development of treatment strategies, the mechanism behind the rela-
tion between OA and CVD is relevant. When OA patients are at risk for
CVD, preventive measures in clinical practice are needed. We investi-
gated whether OA is indeed an additional risk factor for the develop-
ment of CVD, and - since OA and disability are closely related -
examined the role of disability in the association between OA and CVD.
Methods: Our study was embedded in The Rotterdam Study,
a prospective population-based cohort study in a suburb in the city ofRotterdam, the Netherlands. At baseline 4,648 persons aged 55 and
free of CVD were classiﬁed on the basis of radiographs of the knee, hip,
or hand and symptoms of OA into those with and those without OA. For
the assessment of disability the Stanford Health Assessment Ques-
tionnaire was used. We categorized persons as having any disability
versus none, independent of the presence of OA. Hazard ratios adjusted
for cardiovascular risk factors for developing CVD (a composite of
coronary heart disease and stroke) were calculated.
Results: During a median follow-up time of 14.4 years 1,230 cardio-
vascular events (myocardial infarction, surgical or percutaneous coro-
nary revascularisation, coronary mortality and stroke) occurred, of
which 101 in the clinical knee OA group. Presence of radiographic knee
OA, deﬁned as a Kellgren&Lawrence score 2 in at least one joint, was
not related to future CVD (HR 0.99, 95%CI 0.86 to 1.15), neither was
presence of clinical knee OA, deﬁned as a Kellgren&Lawrence score 2
and complaints in the same joint during the last month (HR 1.09, 95%CI
0.88 to 1.34) (see table 1; model 1 was adjusted for age and sex, model 2
was adjusted for age, sex, bodymass index, diabetes, hypertension, total
cholesterol /HDL cholesterol ratio, and current smoking). Results for
hand OA or hip OA were not substantially different from knee OA.
However, persons with increasing disability were more likely to suffer
from a cardiovascular event compared with non-disabled persons (HR
1.26, 95%CI 1.12 to 1.42); this was independent of the presence of OA.
Conclusions: In this population-based study, we found that the pres-
ence of OA was not related to risk of CVD. On the other hand, disability
was a predictor of future CVD independent of the presence of OA. In
clinical practice, having OA is not another red ﬂag to start CVD
prevention apart from established cardiovascular risk factors, such as
hypertension and diabetes. Disability, however, should be prevented,
also in the absence of OA. The close relation between disability and OA
may explain earlier ﬁndings of a relation between OA and risk of CVD.75
P21 REGULATES MMP-13 EXPRESSION THROUGH STAT3 SIGNALING
IN CHONDROCYTES
S. Hayashi, T. Nishiyama, S. Hashimoto, T. Fujishiro, N. Kanzaki,
K. Iwasa, S. Sakata, N. Chinzei, R. Kuroda, M. Kurosaka. Kobe Univ.,
Kobe, Japan
Purpose: Osteoathritis (OA) is a multifactorial disease, and biome-
chanical stress is a major contributor to OA pathology. However, the
underlying mechanisms remain unclear. Recent data have suggested
that cell cycle-related proteins play a role in OA pathology. The cyclin-
dependent kinase inhibitor p21 was initially identiﬁed as a potent
inhibitor of cell cycle progression. Recently, however, it has been
proposed that p21 is a regulator of regulates transcription factor
activity. In this study, we evaluated the role of p21 in the control of gene
expression during the response to cyclic tensile strain, an experimental
model of biomechanical stress.
Methods: Normal human knee chondrocytes (Cambrex, Charles City,
IA) were cultured and used in this study. Chondrocytes were treated
with p21-speciﬁc siRNA, and cyclic tensile strain was introduced in the
presence or absence of a STAT3-speciﬁc inhibitor. Eight-week-old male
C57BL/6J mice were used in this experiment. Destabilization of the
medial meniscus (DMM) was induced in the right knee joint and sham
surgery was performed in the left knee joint. Mice were sacriﬁced at 12
weeks after DMM surgery and subjected to extraction of mRNA.
Results: The expression of MMP-13 mRNA increased in response to 5%
cyclic tensile strain following transfection with p21 siRNA, whereas the
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MMP-13 mRNA levels were increased by downregulation of p21, and
this was reversed by treatment with a STAT3 inhibitor (Figure 2a, b).
Downregulation of p21 also decreased proteoglycan synthesis (Figure
2c). In a mouse OA model and in human primary chondrocytes, we
found that p21 mRNA levels were reduced, whereas SDF-1 and CXCR4
expression was increased (Figure 3). In OA primary chondrocytes,
expression of p21 is decreased and phosphorylation of STAT3 signiﬁ-
cantly increased (data not shown).
Conclusions: Our results suggest that p21 in chondrocytes functions to
maintain matrix synthesis by regulation of aggrecan and MMP-13
expression via STAT3 phosphorylation. Because p21 levels are reduced
in OA chondrocytes, our data imply that stabilization of p21 may be
a therapeutic strategy for OA treatment.Fig 1. Knockdown efﬁciency of p21 siRNA transfection to human normal Chondrocytes
in response to 0%, 5%, and 10% cyclic tensile strain. The concentration of p21 siRNA is
150 nM. Expression levels of p21, COL2A1, ACAN, MMP-3, MMP-13, ADAMTS-4, and
ADAMTS-5 mRNA were quantiﬁed by real-time PCR.Fig 2. The effect of a STAT3-speciﬁc inhibitor on p21-regulated ACAN and MMP-13
expression. Chondrocytes were transfected with p21 siRNA or nonspeciﬁc control
siRNA for 12 h, and 0%, 5%, or 10% cyclic stretch stress was introduced for 24 h in the
presence of 50 mM DMSO or STAT3 speciﬁc inhibitor. (a) Expression levels of p21, ACAN,
and MMP-13 mRNAs were quantiﬁed by real-time PCR. (b) p21 and phospho-STAT3
were analyzed by western blotting. (c) Effect of p21 knockdown on sulfated
glycosaminoglycanFig 3. For in vivo experiments, cartilage tissue samples were collected from right knee
(DMM surgery) and left knee (sham control). (a) The sections were stained with
Safranin O and Fast Green. (b) Expression levels of p21, CXCR4, and SDF-1 mRNAs were
quantiﬁed by real-time PCR. Expression ratios of p21, CXCR4 and SDF-1 are shown.
Columns represent mean  SD ratios of DMM/control.
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NO INTERVERTEBRAL DISC WITH A FLAT TIRE, NOVEL HUMAN
ANNULUS FIBROSIS CELL MODELS
G.G. van den Akker y,z, T.J. Welting z, D.A. Surtel z, A. Cremers z, J.W.
Voncken y, L.W. van Rhijn z. yMaastricht Univ., Dept of Molecular
Genetics, Maastricht, Netherlands; zMaastricht Univ., Dept of
Orthopaedic Surgery, Maastricht, Netherlands
Purpose: The integrity of the annulus ﬁbrosis (AF) tissue in the inter-
vertebral disc is crucial to avoid herniation and low back pain. In rela-
tion to disc degeneration, the cell biology and pathology of the AF is
little studied, compared to the nucleus pulposus (NP). To provide
a functional NP microenvironment and support the overall spinal
compartmentalization, however, the integrity of the ﬁbrous AF is
pivotal. As in vitro models to study AF cells are not available, we set out
to generate clonal cell lines derived from the human annulus ﬁbrosis.
Methods: Non-degenerated human disc material was obtained from
young adolescent donors as surgical surplus material. We immortalized
early passage monolayer cultures by retroviral expression of the
SV40LTAg and hTERT genes. We generated 33 clonal cell lines from the
immortal AF cell pool using a limiting dilution method and mRNA and
protein markers were measured that in vivo discriminate between the
nucleus pulposus and annulus ﬁbrosis to provide a detailed character-
ization of the AF phenotype.
Results: AF clones yielded a predominant subtype that morphologically
differed from primary and immortalized cell pools. Isolated AF clones
showed a strong tendency to migrate and become organized in
patterned alignments (Figure 1A). AF clones synthesized mainly
Collagen type I (COL1A1) and little COL2A1 protein (Figure 1 B).
Furthermore AF clones showed high gene expression of FBLN1, COL1A1
and COMP, whereas expression of the NP marker genes CA12, FOXF1
and KRT19 in comparison with NP clones was low. Chondrogenic
differentiation induced down regulation of COL1A1 expression and cells
spontaneously formed compact aggregates within 5-7 days (Figure 1B).
In contrast, nucleus pulposus-derived clones upregulated SOX9 and
COL2A1 expression and formed less dense aggregates. Cell surface
marker expression was determined for CD24, CD44 and multiple MSC
markers in AF and nucleus pulposus clonal cell lines. AF clones were
positive for CD44, CD90 and negative for CD24, CD73 and CD105;
nucleus pulposus cell clones were found positive for all of the CD
